{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-001104","form_type":"8-K","ticker":"NEPH","cik":"0001196298","company_name":"NEPHROS INC","filed_at":"2022-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.604443+00:00","generated_at":"2026-06-27T18:09:18.742478+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nephros reports record FY2021 revenue of $10.4M, guides FY2022 $13-13.5M","bullets":["Preliminary FY2021 net revenue $10.4M (+21% YoY); Q4 revenue $2.8M (+18% YoY).","Issued FY2022 revenue guidance of $13.0M to $13.5M, representing 25-30% growth.","Ended Q4 2021 with ~$7M cash; reinstated revenue guidance practice.","Pathogen Detection Systems revenue $188k in 2021; expects >200% growth in 2022.","Subsidiary SRP received FDA info request for HDF Assist; expects 510(k) clearance H1 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-001104","json":"https://secwatch.observer/filing/0001493152-22-001104.json","markdown":"https://secwatch.observer/filing/0001493152-22-001104.md","text":"https://secwatch.observer/filing/0001493152-22-001104.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1196298/000149315222001104/0001493152-22-001104-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1196298/000149315222001104/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T18:09:18.742478+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}